Class information for:
Level 1: PSORIATIC ARTHRITIS//PSORIAT ARTHRIT PROGRAM//PROGNOSIS STUDIES RHEUMAT DIS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4299 1734 35.2 76%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
669 12548 PSORIASIS//PSORIATIC ARTHRITIS//CALCIPOTRIOL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PSORIATIC ARTHRITIS Author keyword 324 41% 35% 609
2 PSORIAT ARTHRIT PROGRAM Address 63 76% 3% 44
3 PROGNOSIS STUDIES RHEUMAT DIS Address 38 35% 5% 87
4 DACTYLITIS Author keyword 19 44% 2% 33
5 PSORIAT ARTHRIT CLIN Address 18 61% 1% 19
6 PSORS1 Author keyword 15 82% 1% 9
7 TORONTO WESTERN PSORIAT ARTHRIT PROGRAM Address 14 100% 0% 7
8 APREMILAST Author keyword 11 52% 1% 15
9 CASPAR CRITERIA Author keyword 11 100% 0% 6
10 SEATTLE RHEUMATOL ASSOCIATES Address 10 61% 1% 11

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PSORIATIC ARTHRITIS 324 41% 35% 609 Search PSORIATIC+ARTHRITIS Search PSORIATIC+ARTHRITIS
2 DACTYLITIS 19 44% 2% 33 Search DACTYLITIS Search DACTYLITIS
3 PSORS1 15 82% 1% 9 Search PSORS1 Search PSORS1
4 APREMILAST 11 52% 1% 15 Search APREMILAST Search APREMILAST
5 CASPAR CRITERIA 11 100% 0% 6 Search CASPAR+CRITERIA Search CASPAR+CRITERIA
6 PSORIATIC ONYCHO PACHYDERMO PERIOSTITIS 9 83% 0% 5 Search PSORIATIC+ONYCHO+PACHYDERMO+PERIOSTITIS Search PSORIATIC+ONYCHO+PACHYDERMO+PERIOSTITIS
7 ENTHESITIS 7 21% 2% 30 Search ENTHESITIS Search ENTHESITIS
8 PSORIATIC ARTHROPATHY 7 43% 1% 12 Search PSORIATIC+ARTHROPATHY Search PSORIATIC+ARTHROPATHY
9 HLA CW0602 7 67% 0% 6 Search HLA+CW0602 Search HLA+CW0602
10 LATE CORNIFIED ENVELOPE 6 80% 0% 4 Search LATE+CORNIFIED+ENVELOPE Search LATE+CORNIFIED+ENVELOPE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FAMILIAL PSORIASIS 134 80% 5% 82
2 HLA CW6 47 84% 1% 26
3 ADALIMUMAB EFFECTIVENESS 44 100% 1% 16
4 RELATIVE RISK MODEL 38 86% 1% 19
5 CONTROLLED TRIAL IMPACT 33 83% 1% 19
6 JUVENILE ONSET PSORIASIS 32 85% 1% 17
7 INTEROBSERVER RELIABILITY EXERCISE 30 84% 1% 16
8 IMPACT 2 TRIAL 29 88% 1% 14
9 SUSCEPTIBILITY LOCUS PSORS1 27 92% 1% 11
10 PSORS1 27 83% 1% 15

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Psoriatic arthritis: current therapy and future approaches 2015 5 51 82%
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies 2012 139 70 54%
A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis 2012 56 52 90%
Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis 2013 17 15 80%
The Genetics of Psoriasis and Psoriatic Arthritis 2013 16 72 82%
Treatment recommendations for psoriatic arthritis 2009 166 33 58%
New treatment paradigms in psoriatic arthritis: an update on new therapeutics approved by the US Food and Drug Administration 2015 1 36 67%
Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis 2014 14 159 49%
New developments in our understanding of psoriatic arthritis and their impact on the diagnosis and clinical management of the disease 2014 5 49 90%
Psoriatic Arthritis: a Critical Review 2013 9 32 88%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PSORIAT ARTHRIT PROGRAM 63 76% 2.5% 44
2 PROGNOSIS STUDIES RHEUMAT DIS 38 35% 5.0% 87
3 PSORIAT ARTHRIT CLIN 18 61% 1.1% 19
4 TORONTO WESTERN PSORIAT ARTHRIT PROGRAM 14 100% 0.4% 7
5 SEATTLE RHEUMATOL ASSOCIATES 10 61% 0.6% 11
6 RHEUMATOL LUCANIA 9 31% 1.5% 26
7 ST CLA MERCY HOSP 9 59% 0.6% 10
8 UNIV HLTH NETWORK PROGNOSIS STUDIES RHEUMAT D 8 100% 0.3% 5
9 SWEDISH MED 7 26% 1.3% 23
10 ASSISTANCE PUBL DERMATOL 6 80% 0.2% 4

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000209481 UNIT MULTIDISCIPLINARY INVEST BIOMED//PSORIATIC NEPHROPATHY//DERMATOL VENEREOL PAEDIAT DERMATOL
2 0.0000154596 PSORIASIS//EFALIZUMAB//ALEFACEPT
3 0.0000151445 PSORIASIS//TAIYUAN CITY HOSP//MOUSE TAIL TEST
4 0.0000123916 ANKYLOSING SPONDYLITIS//SPONDYLOARTHRITIS//AXIAL SPONDYLOARTHRITIS
5 0.0000092855 SYNOVITIS//CLIN REUMATOL//ENTHESITIS
6 0.0000079273 CHILDHOOD PSORIASIS//JUVENILE PSORIASIS//PERIANAL STREPTOCOCCAL DERMATITIS
7 0.0000071532 YELLOW NAIL SYNDROME//NAIL PSORIASIS//NAIL PSORIASIS SEVERITY INDEX
8 0.0000058289 ANTI TNF ALPHA THERAPIES//GENHOTEL RECH EUROPEEN POLYARTHRITE RHUMATOID//PATHOL RHEUMATOL
9 0.0000057920 HLA B27//HLA B27 SUBTYPES//ERAP1
10 0.0000055642 PSO P27//PSORIASIS PUSTULOSA PALMARIS ET PLANTARIS//ANTI DOUBLE STRANDED DEOXYRIBONUCLEIC ACID